Dr. Paulina Hennig is an academic and clinical research professional with a PhD in Medical Sciences and advanced training in clinical research. She has built a multidisciplinary career spanning translational research, oncology, dermatology, immunology, and clinical trial operations, with experience supporting studies across Switzerland, the EU, the USA, and international academic environments. Her background combines strong scientific rigor with hands-on operational expertise in patient-centered clinical research.

Dr. Hennig earned her PhD from ETH Zurich in 2022. She also holds a Master of Science in Genetics from the University of Lodz and the University of Virginia, as well as a Bachelor of Science in Biotechnology from the University of Lodz. She further strengthened her clinical research expertise by completing the Certificate of Advanced Studies (CAS) in Clinical Research I at the University of Basel in 2024.

From 2017 to 2024, she worked at the University Hospital Zurich, where she independently led and managed multiple research projects in skin cancer, dermatological disorders, and immunology. Her work included complex data analysis, scientific publishing, and mentoring students and junior team members. During this time, she developed deep subject-matter expertise and contributed extensively to academic research, including 15 peer-reviewed publications in high-impact journals, as well as more than 25 oral and poster presentations. She also played a key role in fostering a collaborative and high-performing research environment.

She subsequently expanded her focus to clinical operations and trial coordination. At the ETOP IBCSG Partners Foundation in Bern, she supported the Program for Young Patients in breast cancer research, contributing to project coordination and clinical trial data management. She also served as a Clinical Research Coordinator at Hirslanden Klinik St. Anna, where she coordinated oncology studies in breast and prostate cancer, supported study start-up activities, ensured data integrity, and contributed to audit readiness and risk mitigation.

Dr. Hennig is recognized for her strong project and time management skills, analytical mindset, and structured approach to problem-solving. She works independently while maintaining a collaborative and team-oriented perspective. Alongside her scientific and operational expertise, she has completed Good Clinical Practice (GCP) training and brings hands-on experience in clinical trial operations, with a strong commitment to regulatory compliance. She is passionate about advancing innovative, patient-centered therapies through high-quality research and effective cross-functional collaboration.